Personalised Medicine Approaches to Screening and Prevention (Q40197199)

18 September 2017

title

Personalised Medicine Approaches to Screening and Prevention (English)

1 reference

18 September 2017

Kezia Gaitskell

1 reference

18 September 2017

publication date

1 April 2017

1 reference

The New bioethics : a multidisciplinary journal of biotechnology and the body

18 September 2017

published in

1 reference

18 September 2017

1 reference

18 September 2017

1 reference

18 September 2017

page(s)

21-29

1 reference

Newborn Sequencing in Genomic Medicine and Public Health

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

Interpretation of the evidence for the efficacy and safety of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

P4 medicine: how systems medicine will transform the healthcare sector and society

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

A new social contract for medical innovation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

Avoiding 40% of the premature deaths in each country, 2010-30: review of national mortality trends to help quantify the UN sustainable development goal for health

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening†

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F20502877.2017.1314884

10.1080/20502877.2017.1314884

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference